Apple, Netflix, Biogen, Canopy Growth and more

A Biogen facility in Cambridge, Massachusetts.

Brian Snyder | Reuters

Find out which companies are making headlines in the midday business.

Apple – Apple shares fell 3.4% on Wednesday following a report that the company is abandoning plans to ramp up production of new iPhones. Instead of aiming to increase production by 6 million units in the second half as it had planned, it will target 90 million units, unchanged from a year earlier, according to Bloomberg.

Biogen – Shares of the biopharmaceutical company soared 37% following upbeat results from its experimental Alzheimer’s drug study and a host of analyst upgrades. Biogen and its Japanese partner Eisai said the drug reduced cognitive decline by 27% and slowed disease progression.

Broadridge – Spruce Point Capital Management released a report with a strong sell view, saying it sees up to 75% downside risk.

Illumina — The biotech company saw its shares climb 8% after Evercore ISI upgraded the stock to outperform the line, saying it is bullish on new Illumina products as it exits of a period of “multi-year underperformance”.

Netflix – Shares of the streaming giant jumped more than 6% after Atlantic Equities upgraded the stock to overweight, saying Netflix’s lower-cost, ad-supported subscriber tier than it plans to launch in the coming months, could increase its share price by 26%.

Thor Industries – Shares jumped 3.4% after the recreational vehicle maker beat expectations for profit and revenue in its latest quarter. Thor said its motorized RV segment saw a 24.5% gain over the prior year.

Ocugen – Shares of the drugmaker soared about 8% after it entered into a licensing agreement with Washington University in St. Louis to develop, market and manufacture its intranasal Covid-19 vaccine.

Canopy Growth – Shares of the cannabis company rose 2.6% on its plans to exit its retail operations in Canada. Ontario-based Canopy said earlier this year it was extending its profitability schedule.

DocuSign – Shares of the electronic signature service rose about 5.4% after announcing on Wednesday that it would cut about 9% of its workforce as part of a restructuring. The company expects to incur costs of up to $40 million under the plan.

Paychex – Shares of the payroll company gained more than 2% after earnings and revenue before the bell beat expectations. It also raised its earnings outlook for the year.

– CNBC’s Alex Harring, Samantha Subin, Michelle Fox and Sarah Min contributed reporting

cnbc Business

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button